Kovács, Dominika and Vántus, Viola and Vámos, Eszter and Kálmán, Nikoletta and Schicho, Rudolf and Gallyas, Ferenc and Radnai, Balázs (2021) Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn’s Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. ISSN 1942-0900
|
Text
Kovacs D et al, 2021 - Olaparib.pdf Download (2MB) | Preview |
Official URL: https://doi.org/10.1155/2021/7308897
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában > R850-854 Experimental medicine / kisérleti orvostudomány R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan |
| Depositing User: | Dr. Balázs Radnai |
| Date Deposited: | 27 Sep 2021 06:40 |
| Last Modified: | 08 May 2023 07:37 |
| URI: | http://real.mtak.hu/id/eprint/130573 |
Actions (login required)
 |
Edit Item |
